Krishna Sukla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Krishna Sukla has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Amit Kumar
Banaras Hindu University
1 shared publication - Binuja Varma
TCS Genomics Lab, Tata Consultancy Services Limited, Noida, Uttar Pradesh, India 201313
1 shared publication Brennan Harmon
Center for Genetic Medicine Research, Children’s National Hospital, Washington, D.C., USA
1 shared publication- Chandrani Bose
Life Sciences R&I, TCS Research, Tata Consultancy Services Limited, Hinjewadi Phase-III, Pune, India
1 shared publication - Chittaranjan Sakerlal Yajnik
Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India
1 shared publication Dattatray Bhat
Diabetes Unit, KEM Hospital Research Centre, Pune, India
1 shared publication
Latest Publications
- Open Access
- 30 August 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation
Breast cancer, the most common cancer in women worldwide, is linked to microbiome imbalances. This suggests the potential for microbiome-based breast cancer management. However, a comprehensive and reproducible understanding of the microbiome’s role in breast cancer is lacking. We conducted a systematic literature review to explore microbiome signatures and specific genera associated with breast cancer development, subtypes, and outcomes. We searched PubMed, Embase, Scopus, and Web of Science using the terms “microbiome” and “breast cancer”, limiting to publications of human studies in English language between January 2011 and January 2025, and adhering to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. We extracted the study characteristics and results and summarized our findings. From 2536 articles, we identified 48 eligible studies – 22 case-control, 13 cohorts without any intervention, and 13 cohorts with an intervention. These studies included 3735 women with and 2023 without a diagnosis of breast cancer. Most studies used fecal (29) or breast tissue (14) samples. The genera Clostridium, Lcatobacillus, Prevotella were most commonly associated with breast cancer. However, no genus was consistently linked to the same outcome across studies, rendering meta-analysis unfeasible. Overall, we observed heterogenous methods for data generation and computational analysis leading to challenges in comparative analysis. While several genera are linked to breast cancer, the findings lack consistency across studies. Future studies should employ standardized outcomes, data collection, and processing methods to establish reproducible microbial markers to develop effective microbiome-based breast cancer management strategies.
- 30 August 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Open AccessBreast cancer and microbiome: a systematic review highlighting challenges for clinical translation
Breast cancer, the most common cancer in women worldwide, is linked to microbiome imbalances. This suggests the potential for microbiome-based breast cancer management. However, a comprehensive and reproducible understanding of the microbiome’s role in breast cancer is lacking. We conducted a systematic literature review to explore microbiome signatures and specific genera associated with breast cancer development, subtypes, and outcomes. We searched PubMed, Embase, Scopus, and Web of Science using the terms “microbiome” and “breast cancer”, limiting to publications of human studies in English language between January 2011 and January 2025, and adhering to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. We extracted the study characteristics and results and summarized our findings. From 2536 articles, we identified 48 eligible studies – 22 case-control, 13 cohorts without any intervention, and 13 cohorts with an intervention. These studies included 3735 women with and 2023 without a diagnosis of breast cancer. Most studies used fecal (29) or breast tissue (14) samples. The genera Clostridium, Lcatobacillus, Prevotella were most commonly associated with breast cancer. However, no genus was consistently linked to the same outcome across studies, rendering meta-analysis unfeasible. Overall, we observed heterogenous methods for data generation and computational analysis leading to challenges in comparative analysis. While several genera are linked to breast cancer, the findings lack consistency across studies. Future studies should employ standardized outcomes, data collection, and processing methods to establish reproducible microbial markers to develop effective microbiome-based breast cancer management strategies.
- 13 December 2023
- Published by Springer Nature in International Journal of Obesity
- Vol. 48 (3) , 403-413
Neonatal adiposity is associated with microRNAs in adipocyte-derived extracellular vesicles in maternal and cord blood, a discovery analysis
Background Maternal body size, nutrition, and hyperglycemia contribute to neonatal body size and composition. There is little information on maternal-fetal transmission of messages which influence fetal growth. We analyzed adipocyte-derived small extracellular vesicular (ADsEV) microRNAs in maternal and cord blood to explore their adipogenic potential. Methods There were 279 mother-neonate pairs with all phenotypic data (normal glucose tolerant NGT = 148, gestational diabetes mellitus GDM = 131). Neonates with adiposity were those in the highest tertile (T3) of sex-specific sum of skinfolds and those without adiposity (lean) in the lowest tertile T1 of NGT pregnancies. We studied ADsEV miRNAs in 76 and 51 neonates with and without adiposity respectively and their mothers based on power calculations (68 NGT and 59 GDM pregnancies). ADsEV miRNAs from maternal and cord blood plasma samples were profiled on Agilent 8*60 K microarray. Differential expression (DE) of ADsEV miRNAs in adipose vs. lean groups was studied before and after adjustment for maternal GDM, adiposity, and vitamin B12-folate status. Results Multiple miRNAs were common in maternal and cord blood and positively correlated. We identified 24 maternal and 5 cord blood miRNAs differentially expressed (discovery p ≤ 0.1) in the adipose group in unadjusted, and 19 and 26, respectively, in the adjusted analyses. Even though DE miRNAs were different in maternal and cord blood, they targeted similar adipogenic pathways (e.g., the forkhead box O (FOXO) family of transcription factors, mitogen‑activated protein kinase (MAPK) pathway, transforming growth factor beta (TGF-β) pathway). Maternal GDM and adiposity were associated with many DE ADsEV miRNAs. Conclusion Our results suggest that the ADsEV miRNAs in mothers are potential regulators of fetal adiposity. The expression and functionality of miRNAs appear to be influenced by maternal adiposity, hyperglycemia, and micronutrient status during pregnancy.
- 13 December 2023
- Published by Springer Nature in International Journal of Obesity
- Vol. 48 (3) , 403-413
Neonatal adiposity is associated with microRNAs in adipocyte-derived extracellular vesicles in maternal and cord blood, a discovery analysis
Background Maternal body size, nutrition, and hyperglycemia contribute to neonatal body size and composition. There is little information on maternal-fetal transmission of messages which influence fetal growth. We analyzed adipocyte-derived small extracellular vesicular (ADsEV) microRNAs in maternal and cord blood to explore their adipogenic potential. Methods There were 279 mother-neonate pairs with all phenotypic data (normal glucose tolerant NGT = 148, gestational diabetes mellitus GDM = 131). Neonates with adiposity were those in the highest tertile (T3) of sex-specific sum of skinfolds and those without adiposity (lean) in the lowest tertile T1 of NGT pregnancies. We studied ADsEV miRNAs in 76 and 51 neonates with and without adiposity respectively and their mothers based on power calculations (68 NGT and 59 GDM pregnancies). ADsEV miRNAs from maternal and cord blood plasma samples were profiled on Agilent 8*60 K microarray. Differential expression (DE) of ADsEV miRNAs in adipose vs. lean groups was studied before and after adjustment for maternal GDM, adiposity, and vitamin B12-folate status. Results Multiple miRNAs were common in maternal and cord blood and positively correlated. We identified 24 maternal and 5 cord blood miRNAs differentially expressed (discovery p ≤ 0.1) in the adipose group in unadjusted, and 19 and 26, respectively, in the adjusted analyses. Even though DE miRNAs were different in maternal and cord blood, they targeted similar adipogenic pathways (e.g., the forkhead box O (FOXO) family of transcription factors, mitogen‑activated protein kinase (MAPK) pathway, transforming growth factor beta (TGF-β) pathway). Maternal GDM and adiposity were associated with many DE ADsEV miRNAs. Conclusion Our results suggest that the ADsEV miRNAs in mothers are potential regulators of fetal adiposity. The expression and functionality of miRNAs appear to be influenced by maternal adiposity, hyperglycemia, and micronutrient status during pregnancy.
- 13 December 2014
- Published by Springer Nature in Journal of Genetics
- Vol. 93 (3) , 865-868
Overlap of Patau and Pierre Robin syndromes along with abnormal metabolism: an interesting case study
- 13 December 2014
- Published by Springer Nature in Journal of Genetics
- Vol. 93 (3) , 865-868
Overlap of Patau and Pierre Robin syndromes along with abnormal metabolism: an interesting case study